SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001013762-23-000418
Filing Date
2023-10-02
Accepted
2023-10-02 16:00:24
Documents
1
Period of Report
2023-09-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 2375
  Complete submission text file 0001013762-23-000418.txt   3776
Mailing Address 5858 HORTON STREET, SUITE 170 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 170 EMERYVILLE CA 94608 (510) 318-9098
Estrella Immunopharma, Inc. (Issuer) CIK: 0001844417 (see all company filings)

IRS No.: 861314502 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 15 EAST 32ND STREET, 2ND FLOOR NEW YORK NY 10016
Business Address
Long James (Reporting) CIK: 0001868482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40608 | Film No.: 231299517